Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 164   

Articles published

VRX 20.27 -1.98 (-8.90%)
price chart
Valeant Pharmaceuticals International Inc stock dives after profit misses ...
Valeant Pharmaceuticals International Inc. cut its 2016 profit forecast as new Chief Executive Officer Joseph Papa starts his attempt to turn around the embattled drugmaker.
S&P/TSX Composite index up on Suncor, banks; Valeant Pharmaceuticals ...  Midas Letter
VRX Stock: Has Valeant Pharmaceuticals Intl Inc Finally Bottomed?  Profit Confidential
Morgan Stanley lowers Valeant Pharmaceuticals Intl Inc Estimates; Here's Why
Research firm Morgan Stanley has lowered its earnings estimates for Valeant Pharmaceuticals Intl. Inc. (NYSE:VRX) today.
Phillipe Laffont's Latest Investment Moves: Valeant Pharmaceuticals Intl ...  Smarter Analyst
Valeant Pharmaceuticals Intl Inc Gains Despite Downgrade  ValueWalk
U.S. government joins whistleblower lawsuit against Valeant Pharmaceuticals ...
NEW YORK - The United States has joined a whistleblower lawsuit accusing the Salix unit of Valeant Pharmaceuticals International Inc of paying illegal kickbacks to doctors and submitting fraudulent reimbursement claims to the government. In a ...
Can Valeant Pharmaceuticals Intl Inc. Recover?  The Motley Fool Canada
Most Active Weekly Options: Apple Inc. and Valeant Pharmaceuticals Intl Inc  Schaeffers Research (blog)
Can Investors Expect Anything Good From Valeant Pharmaceuticals Intl Inc.?
It seems every week there is another problem with Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). Bond holders are hinting that Valeant will default on its debt and wind up losing everything.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Down Amid M&A Talks, Street ...  TCC
Insider Trading News: Valeant Pharmaceuticals Intl Inc (VRX), American ...  Smarter Analyst
Valeant Pharmaceuticals International Inc stock shoots up after report it ...
Valeant Pharmaceuticals International Inc. received a takeover approach this spring from Takeda Pharmaceutical Co. and investment firm TPG, which it rejected, the Wall Street Journal has reported, citing people familiar with the matter.
Valeant Pharmaceuticals International Inc. (VRX) Stock Price Surges On News ...  International Business Times
Last-Minute Call Buyers Target Valeant Pharmaceuticals Intl Inc (VRX)  Schaeffers Research (blog)
Valeant Pharmaceuticals Intl Inc (VRX) Announces Significant Investments In ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced that its wholly-owned subsidiary Valeant Canada is expanding its Canadian manufacturing and export capacity with investments totaling $27.5 million in its Steinbach, Manitoba and Laval, Quebec ...
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Invests $27.5 Million ...  TCC
Eye-Catching Stocks: Valeant Pharmaceuticals Intl Inc (NYSE:VRX ...  The Point Review
Valeant Pharmaceuticals International Inc Guides for Strong Prescriptions ...
Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) is expected to see a turnaround in fortunes as RBC Capital analyst Douglas Miehm sees a sharp inline turnaround, with management's guidance in weekly prescriptions for VRX's core drug business.
Update On Top Moving Canadian Stocks: Valeant Pharmaceuticals International ...
Alimentation Couche-Tard Inc. rallied 1.9 percent, paring its slide this month to 7.8 percent, while Maple Leaf Foods Inc. gained 1.6 percent.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Hot News Update – 17 June 2016
The share price of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) declined -90.58 percent for the year. YTD, the current share price of the stock is below -78.32 percent.
Valeant Pharmaceuticals International, Inc. Stock Momentum Hits Extreme Weakness
This is a momentum stock rating analysis for Valeant Pharmaceuticals International, Inc. (NYSE:VRX). The company is now famously known for the accusations Citron research brought against it which has led a stock collapse.